Clinical trials
Phase 1 trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
272 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 13 |
| 2011 | 9 |
| 2012 | 9 |
| 2013 | 20 |
| 2014 | 7 |
| 2015 | 12 |
| 2016 | 19 |
| 2017 | 24 |
| 2018 | 25 |
| 2019 | 15 |
| 2020 | 19 |
| 2021 | 17 |
| 2022 | 17 |
| 2023 | 17 |
| 2024 | 11 |
| 2025 | 15 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 195 |
| Unknown status | 30 |
| Terminated | 18 |
| Recruiting | 14 |
| Active, not recruiting | 12 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biocad | 23 |
| Pharmtechnology LLC | 18 |
| Hoffmann-La Roche | 12 |
| Tomsk National Research Medical Center of the Russian Academy of Sciences | 12 |
| Valenta Pharm JSC | 12 |
| AO GENERIUM | 10 |
| Novartis Pharmaceuticals | 9 |
| Boehringer Ingelheim | 7 |
| GlaxoSmithKline | 7 |
| R-Pharm | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 15 |
| Melanoma | 14 |
| Neoplasms | 14 |
| Arthritis, Rheumatoid | 12 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Influenza, Human | 9 |
| Lung Neoplasms | 7 |
| Lymphoma, Follicular | 6 |
| Multiple Sclerosis | 6 |
| Carcinoma, Renal Cell | 5 |
Trials
Showing 26 to 50 of 272. Each trial links to its page on Pharma Observatory.
172 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.